Evidence map›Paper›PMID 27717328›Full record

ArticleBMC infectious diseases2016

Nationwide distribution of varicella-zoster virus clades in China.

Songtao Xu, Mukai Chen, Huanying Zheng, Haiyan Wang, Meng Chen, Jianhui Zhou, Wang Shuang, Pengbo Yu, Chaofeng Ma, Jilan He and 10 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Genomic sequencing revealed recombination event between clade 1 and clade 2 occurs in circulating varicella-zoster virus in China.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Songtao XuNational Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
Mukai ChenThe First Affiliated Hospital of Sun Yat-sen University, Guangzhou City, 510080, Guangdong Province, China.
Huanying ZhengGuangdong Center for Disease Control and Prevention, Guangzhou City, 510300, Guangdong Province, China.
Haiyan WangShandong Center for Disease Control and Prevention, Jinan City, 250014, Shandong Province, China.
Meng ChenBeijing Center for Disease Control and Prevention, Beijing City, 100021, China.
Jianhui ZhouJilin province Center for Disease Control and Prevention, Changchun City, 130021, Jilin Province, China.
Wang ShuangJilin province Center for Disease Control and Prevention, Changchun City, 130021, Jilin Province, China.
Pengbo YuShaanxi Center for Disease Control and Prevention, Xian City, 710012, Shannxi Province, China.
Chaofeng MaXi'an city Center for Disease Control and Prevention, Xian City, 710031, Shannxi Province, China.
Jilan HeSichuan Center for Disease Control and Prevention, Chengdu City, 610014, Sichuan Province, China.
Daxing FengHenan Center for Disease Control and Prevention, Zhengzhou City, 450016, Henan Province, China.
Zhu ZhenNational Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
Zhang YanNational Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
Mao NaiyingNational Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
Aili CuiNational Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
Qiuhua WuNational Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
Mengyuan QiDepartment of Neurosurgery, Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, Liaoning Province, China.
Chongshan LiShanghai Center for Disease Control and Prevention, Shanghai City, 200336, China. 94114911@qq.com.
Xiaoguang XuDepartment of Neurosurgery, Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, Liaoning Province, China. xuxg2007@sina.com.
Wenbo XuNational Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China. wenbo_xu1@aliyun.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2010, a universal nomenclature for varicella-zoster virus (VZV) clades was established, which is very useful in the monitoring of viral evolution, recombination, spread and genetic diversity. Currently, information about VZV clades has been disclosed worldwide, however, there are limited data regarding the characterization of circulating VZV clades in China, even where varicella remains widely epidemic.

methodsFrom 2008 to 2012, clinical samples with varicella or zoster were collected in General Hospital in eight provinces and analyzed by PCR, restriction endonuclease digestion and sequencing. The viral clades were determined by analysis of five single nucleotide polymorphisms (SNPs) within the 447-bp fragment of open reading frame (ORF) 22, and the restriction fragment length polymorphisms (RFLPs) of ORF 38 (PstI), ORF 54 (BglI) and ORF 62 (SmaI) were evaluated to understand genetic diversity of VZV and determinate varicella vaccine adverse event (VVAE).

resultsSeventy-seven varicella and 11 zoster samples were identified as being positive for VZV. The five SNPs profile showed that the majority of VZV strains belonged to clade 2, but clade 5 and clade 4 strains were also found in Guangdong. The RFLPs analysis of the DNA fragments of ORF 38, 54 and 62 showed that 85 of these samples were characterized as PstI + BglI + SamI-, and the remaining three VZV strains from varicella patients were characterized as PstI-BglI + SamI+ which is the genetic profile of VVAEs.

conclusionsThe study suggested that the predominant clade 2 VZVs had been continually circulating since at least the 1950s in China. Nearly all VZV strains except VVAEs possessed the genetic profile of PstI + BglI + Sam-. However, the other clades were also found to be co-circulating with clade 2, especially in the border regions. These results highlighted the need for the constant and broad use of virologic surveillance to provide an important genetic baseline for varicella control and vaccination programs in China.

Indexed as

AdolescentAdultAgedBiological EvolutionChickenpoxChickenpox VaccineChildChild, PreschoolChinaGenotypeHerpesvirus 3, HumanHerpes ZosterHospitals, GeneralHumansMiddle AgedOpen Reading FramesChickenpox VaccineChinaCladeGenetic profileVaricella vaccine adverse eventVaricella-zoster virus

Identifiers

PMID27717328
PMCPMC5054591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.